Publications by authors named "Albert Font-Pous"

Claim this Profile
P
PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum.
Joshua J Meeks, Michiel S van der Heijden, Thomas Powles, Matthew D Galsky, Hikmat Al-Ahmadie

J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb

Nat Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival.
Javier J Robles Barba, Aida Sabaté Llobera, Cristina Gámez Cenzano, Juan J Martin Marcuartu, Natalia Romero Martínez

Indian J Nucl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
Bernadett Szabados, Mark Kockx, Zoe June Assaf, Pieter-Jan van Dam, Alejo Rodriguez-Vida

Eur Urol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial.
Bernadett Szabados, Alejo Rodriguez-Vida, Ignacio Durán, Simon J Crabb, Michiel S Van Der Heijden

Eur Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.
Joaquim Bellmunt Molins, Jesús García-Donas Jiménez, Begoña P Valderrama, Juan Antonio Virizuela Echaburu, Susana Hernando-Polo

Clin Genitourin Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb

Nat Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb

Nat Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.
Daniel E Castellano, Joaquim Bellmunt, José Pablo Maroto, Albert Font-Pous, Rafael Morales-Barrera

Cancer Chemother Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Renal-cell carcinoma and multiple mieloma: synchronic association with posible immunologic pathogenesis].
José Luis Cuadra-Urteaga, Albert Font Pous, Nuria Pardo-Aranda, Albert Oriol Rocafiguera

Med Clin (Barc)· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM clinical guidelines for the treatment of small-cell lung cancer.
Angel Artal Cortés, Manuel Dómine Gómez, Albert Font Pous, Rosario García Campelo, Manuel Cobo Dolls

Clin Transl Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Study of effectiveness of 3 schedules of administration of erythropoietic colony-stimulating factors in anemic patients under chemotherapy for solid or hematology malignancy].
José Luis Pontón Sivillá, Evaristo Feliu Frasnedo, Pilar Modamio Charles, Eduardo L Mariño Hernández, Albert Font Pous

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis